[go: up one dir, main page]

ES8702402A1 - Un metodo para preparar un derivado de 1-piperazin-3-feni- lindano - Google Patents

Un metodo para preparar un derivado de 1-piperazin-3-feni- lindano

Info

Publication number
ES8702402A1
ES8702402A1 ES548204A ES548204A ES8702402A1 ES 8702402 A1 ES8702402 A1 ES 8702402A1 ES 548204 A ES548204 A ES 548204A ES 548204 A ES548204 A ES 548204A ES 8702402 A1 ES8702402 A1 ES 8702402A1
Authority
ES
Spain
Prior art keywords
treatment
formula
preparation
methods
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES548204A
Other languages
English (en)
Other versions
ES548204A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of ES548204A0 publication Critical patent/ES548204A0/es
Publication of ES8702402A1 publication Critical patent/ES8702402A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/32—One oxygen atom
    • C07D233/36—One oxygen atom with hydrocarbon radicals, substituted by nitrogen atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/30—Oxygen or sulfur atoms
    • C07D233/42—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom
    • C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/38—One sulfur atom
    • C07D239/40—One sulfur atom as doubly bound sulfur atom or as unsubstituted mercapto radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/95—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96—Two oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18—Oxygen atoms
    • C07D263/20—Oxygen atoms attached in position 2
    • C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Cephalosporin Compounds (AREA)
  • Catalysts (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)

Abstract

METODO PARA PREPARAR DERIVADOS DE 1-PIPERAZIN-3-FENILINDANO. CONSISTENTE EN: HACER REACCIONAR UN COMPUESTO DE FORMULA (IV) CON UN COMPUESTO DE FORMULA (V), EN UN DISOLVENTE INERTE TAL COMO METILETILCETONA O ETANOL, EN PRESENCIA DE UN CARBONATO DE METAL ALCALINO COMO EL CARBONATO POTASICO, A LA TEMPERATURA DE REFLUJO DE LA MEZCLA DE REACCION, PARA OBTENER LOS COMPUESTOS DE FORMULA (I). SIENDO: R1 F H, HALOGENO, METOXI, METILTIO Y OTROS; N ES 2-4; X ES O O S; Y ES O, CH2 O N-R2; R2 ES H, UN GRUPO ALQUILO DE 1 A 6C U OTROS; Z ES -(CH2)N- U OTROS; N ES 2 O 3; U ES N O C; A ES HALOGENO U OSO2R; Y R ES ALQUILO O ARILO. UTILIZABLE COMO FARMACO EN EL TRATAMIENTO DE LA HIPERTENCION Y LAS ENFERMEDADES CARDIOVASCULARES.
ES548204A 1984-10-26 1985-10-25 Un metodo para preparar un derivado de 1-piperazin-3-feni- lindano Expired ES8702402A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB848427125A GB8427125D0 (en) 1984-10-26 1984-10-26 Organic compounds

Publications (2)

Publication Number Publication Date
ES548204A0 ES548204A0 (es) 1987-01-01
ES8702402A1 true ES8702402A1 (es) 1987-01-01

Family

ID=10568794

Family Applications (1)

Application Number Title Priority Date Filing Date
ES548204A Expired ES8702402A1 (es) 1984-10-26 1985-10-25 Un metodo para preparar un derivado de 1-piperazin-3-feni- lindano

Country Status (18)

Country Link
US (1) US4684650A (es)
EP (1) EP0183349B1 (es)
JP (1) JPH0655718B2 (es)
AT (1) ATE57182T1 (es)
AU (2) AU595167B2 (es)
CA (1) CA1247098A (es)
DE (1) DE3580000D1 (es)
DK (1) DK493485A (es)
ES (1) ES8702402A1 (es)
FI (1) FI84174C (es)
GB (1) GB8427125D0 (es)
GR (1) GR852586B (es)
IE (1) IE58861B1 (es)
IL (1) IL76538A (es)
NO (1) NO160075C (es)
NZ (1) NZ213577A (es)
PT (1) PT81371B (es)
ZA (1) ZA857341B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE58370B1 (en) * 1985-04-10 1993-09-08 Lundbeck & Co As H Indole derivatives
US5322851A (en) * 1990-07-02 1994-06-21 H. Lundbeck A/S Indole derivatives
DK158590D0 (da) * 1990-07-02 1990-07-02 Lundbeck & Co As H Indolderivater
DK286990D0 (da) * 1990-12-04 1990-12-04 Lundbeck & Co As H Indanderivater
US5643784A (en) * 1990-12-04 1997-07-01 H, Lundbeck A/S Indan derivatives
NZ243065A (en) * 1991-06-13 1995-07-26 Lundbeck & Co As H Piperidine derivatives and pharmaceutical compositions
DK55192D0 (da) * 1992-04-28 1992-04-28 Lundbeck & Co As H 1-piperazino-1,2-dihydroindenderivater
DK78692D0 (da) * 1992-06-12 1992-06-12 Lundbeck & Co As H Dimere piperidin- og piperazinderivater
US7049146B2 (en) * 2000-11-14 2006-05-23 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
US7122376B2 (en) * 2001-11-01 2006-10-17 Facet Analytical Services And Technology, Llc Calibration standards, methods, and kits for water determination
WO2004027361A1 (en) * 2002-09-17 2004-04-01 University Of Virginia Patent Foundation Remote temperature sensing of small volume and related apparatus thereof
DK3135656T3 (en) 2011-06-20 2019-04-23 H Lundbeck As DEUTERATED 1-PIPERAZINO-3-PHENYL INDANES FOR TREATMENT OF schizophrenia
WO2017082130A1 (ja) * 2015-11-13 2017-05-18 東洋紡株式会社 積層ポリエステルフィルム
WO2020114853A1 (en) 2018-12-03 2020-06-11 H. Lundbeck A/S Prodrugs of 4-((1r,3s)-6-chloro-3-phenyl-2,3-dihydro-1h-inden-1-yl)-1,2,2-trimethylpiperazine and 4-((1/r,3s)-6-chloro-3-(phenyl-d5)-2,3-dihydro-1h-inden-1-yl)-2,2-dimethy-1-(methyl-d3)piperazine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL57569A0 (en) * 1978-06-20 1979-10-31 Synthelabo Phenylpiperazine derivative,their preparation and pharmaceutical compositions containing them
IE50867B1 (en) * 1980-02-29 1986-08-06 Kefalas As Indane derivatives

Also Published As

Publication number Publication date
FI84174C (fi) 1991-10-25
IL76538A0 (en) 1986-02-28
IL76538A (en) 1989-09-10
AU4796590A (en) 1990-05-10
GR852586B (es) 1986-02-26
ZA857341B (en) 1986-09-24
GB8427125D0 (en) 1984-12-05
PT81371B (pt) 1987-11-11
IE852285L (en) 1986-04-26
NO854305L (no) 1986-04-28
ES548204A0 (es) 1987-01-01
US4684650A (en) 1987-08-04
FI84174B (fi) 1991-07-15
PT81371A (en) 1985-11-01
DK493485A (da) 1986-04-27
ATE57182T1 (de) 1990-10-15
DK493485D0 (da) 1985-10-25
NO160075C (no) 1989-03-08
CA1247098A (en) 1988-12-20
EP0183349A1 (en) 1986-06-04
NZ213577A (en) 1988-11-29
AU4910685A (en) 1986-05-01
DE3580000D1 (de) 1990-11-08
AU595167B2 (en) 1990-03-29
FI853951A0 (fi) 1985-10-10
JPH0655718B2 (ja) 1994-07-27
JPS61171466A (ja) 1986-08-02
NO160075B (no) 1988-11-28
EP0183349B1 (en) 1990-10-03
FI853951L (fi) 1986-04-27
IE58861B1 (en) 1993-11-17

Similar Documents

Publication Publication Date Title
ES8702402A1 (es) Un metodo para preparar un derivado de 1-piperazin-3-feni- lindano
ES8103089A1 (es) Metodo para preparar nuevas espiro (dihidrobenzofuran-pipe- ridinas y -pirrolidinas)
ES8600263A1 (es) Un compuesto.
ES8101536A1 (es) Procedimiento para preparar nuevos derivados de pleuromuti- lin
ATE10939T1 (de) Verwendung von 1,3-dioxolen-2-on-derivaten.
ES8705411A1 (es) Procedimiento para preparar derivados de 1-piperazinacarboxamida
ZA832203B (en) Thiomethylpyridine derivatives process for the production thereof and medicaments containing them
ES8706644A1 (es) Un procedimiento para preparar derivados de dihidropiridazina
GB1505020A (en) Substituted 2-phenylimino-thiazolines a process for their preparation and their use as ectoparasiticides
ES8702399A1 (es) Un procedimiento para preparar derivdos de 1,5-benzoxatiepina
ES454267A1 (es) Un procedimiento para la produccion de un nuevo derivado de aminoacidos.
ES328674A1 (es) Procedimiento para la produccion de alcaloides.
ES419739A1 (es) Procedimiento para la preparacion de 2-arilamino-imidazoli-nas (2) sustituidas.
GB1393750A (en) Bis-1,2,4-triazolyl 5- compounds and their use as optical brightening agents
ES466455A1 (es) Procedimiento para la preparacion de un nuevo derivado de 6-caprolactama.
DE3465737D1 (en) Process for the preparation of 4-quinolinones
JPS54109973A (en) Novel imidazole derivative
ES476164A1 (es) Procedimiento para la preparacion de nuevos derivados espec-tinomicinicos.
ES425046A1 (es) Un procedimiento para la produccion de nuevos tiazolotria- zolilfosfonotioatos.
JPS51141868A (en) Process for preparing novel 3-substituted-n-benzylprrolidine derivativ es.
ES8202337A1 (es) Procedimiento para la preparacion de nuevos derivados de 2-(4 aminopiperidino)-3,4-dihidroquinoleina
ES8107225A1 (es) Procedimiento para la obtencion de nuevas penicilinas
ES456093A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-tiazolinil bencimidazoles 5(6)-sustituidos.
ES467249A1 (es) Un procedimiento para la obtencion de 2-(3-metil-2-furoil)- 1, 4, 5-trimetil-1, 2, 3, 6-tetrahidropiridina.
JPS51146481A (en) Process for preparing arabinofuranosylcytosine derivatives